Viewing nowCombinationPimaces Tablet 30/2.5 mg
Fimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.

MFDS item code 202300426 · Approved 2023.01.31 · Insurance code 653405300
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Used as an additional treatment option for patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy of pimasartan potassium.
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted with fimarsartan before starting this medicine; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimarsartan 30 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimarsartan 60 mg monotherapy. Patients taking fimarsartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary in elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment with fimarsartan 30 mg of this medicine should be initiated. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Safety and efficacy have not been established in pediatric and adolescent patients 18 years of age or younger.
This medication may cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Additionally, it should not be used in patients with allergies to its components or specific health conditions, such as those with kidney dialysis, severe liver impairment, or biliary obstruction. Careful monitoring is necessary when administering this drug to patients with depleted blood volume or sodium, impaired renal function, certain heart diseases, and the elderly. If side effects such as dizziness, headache, swelling, urinary disorders, insomnia, or flushing occur while taking this medication, medical consultation should be sought. Blood pressure may drop too low, so immediate treatment is required if symptoms of hypotension appear, and regular tests are needed due to the risk of increased potassium levels in the blood. This medication can interact with other antihypertensive agents or specific drugs, so patients must inform their healthcare provider if they are taking other medications. It is recommended that pregnant or breastfeeding women do not take this medication, particularly during pregnancy due to risks to the fetus. Safety and efficacy in children and adolescents under 18 years of age have not been established, so it is best not to use it. In case of overdose, symptoms such as blood pressure drop or heart-related issues may arise, requiring immediate hospital treatment. Keep this medication out of the reach of children and do not transfer it to another container to ensure safety.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that protects it from light. It is also recommended to store it at room temperature between 1°C and 30°C. This helps maintain the medication's effectiveness and safety.
White round film-coated tablet
Bottle packaging - 30 tablets/bottle, Bottle packaging - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate Dihydrate 3.69mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Allico Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Allyco Pharmaceutical Co., Ltd.
S-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Hana Pharmaceutical Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication · Combination
Hana Pharm Co., Ltd.
CombinationS-Amlodipine Besylate Dihydrate 3.69mg · Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.